Web-based vs In-person Personalized Feedback Intervention for Comorbid Substance Use and Disordered Gambling
Study Details
Study Description
Brief Summary
Rates of gambling and substance use behaviors are elevated among emerging adults (ages 18-24), and these behaviors are individually and jointly associated with a host of negative consequences. Evidence suggests there is significant overlap between these behaviors as well as comorbidity of associated mental disorders (i.e., pathological gambling and substance abuse/dependence). Prior research suggests that a brief in-person delivered personalized feedback intervention (PFI) may be an effective method of reducing these behaviors and their associated consequences among emerging adults. Thus, the purpose of this study is to determine the relative efficacy of an in-person delivered PFI versus a Web-based PFI in reducing gambling, alcohol and marijuana use behaviors and related-consequences in a sample of emerging adults, as well as explore potential moderators and mediators of intervention efficacy and the longevity of intervention effects (over a period of 18-months).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: In-person PFI In-person personalized feedback intervention |
Behavioral: Personalized Feedback Intervention
Printed or electronic form containing personalized information about health-relevant behaviors
|
Experimental: Web-based PFI Web-based personalized feedback intervention |
Behavioral: Personalized Feedback Intervention
Printed or electronic form containing personalized information about health-relevant behaviors
|
No Intervention: Assessment Only Complete online survey assessments only. |
Outcome Measures
Primary Outcome Measures
- gambling behavior and consequences [across 18 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Endorse disordered gambling behavior (including 1 or more consequence)
-
Meet diagnostic criteria for one or more substance use disorder
Exclusion Criteria:
- Not meeting inclusion criteria
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Washington | Seattle | Washington | United States | 98195 |
Sponsors and Collaborators
- University of Washington
- National Institute on Drug Abuse (NIDA)
Investigators
- Principal Investigator: Mary E Larimer, Ph.D., University of Washington Dept of Psychiatry & Behavioral Sciences
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 35898-C
- R01DA025051